Literature DB >> 7890383

Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo.

T A Russo1, G Sharma, C R Brown, A A Campagnari.   

Abstract

The O-specific antigen in extraintestinal isolates of Escherichia coli is believed to be an important virulence factor. To assess its role in the pathogenic process, proven isogenic derivatives with either a complete (CP921) or nearly complete (CP920) deficiency of the O4 antigen were obtained by TnphoA'1-mediated transposon mutagenesis of an O4/K54/H5 blood isolate (CP9). By utilizing a previously reported isogenic K54 capsule-deficient derivative (CP9.137), additional isogenic derivatives deficient in both the K54 capsular antigen and either all (CP923) or nearly all (CP922) of the O4 antigen were also constructed. These strains and their wild-type parent were evaluated in vitro for serum sensitivity and in vivo by intraperitoneal challenge of outbred mice. The complete or nearly complete loss of the O4 antigen (CP920 and CP921) resulted in only a minor increase in serum sensitivity. In contrast, CP9.137 had a significant increase in serum sensitivity, and CP922 and CP923 were extremely serum sensitive. When tested in vivo, the complete or nearly complete loss of the O4 antigen resulted in a small but significant increase (P < or = 0.05), not the expected decrease, in virulence compared with its wild-type parent. In contrast, CP9.137 and CP922 were significantly less virulent (P < or = 0.05). These studies do not exclude a role for the O4 antigen moiety of lipopolysaccharide in the pathogenesis of extraintestinal E. coli infection; however, they demonstrate that the O4 antigen plays only a minor role in serum resistance in vitro and that its loss does not diminish and perhaps enhances the virulence of CP9 in vivo after intraperitoneal challenge.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890383      PMCID: PMC173145          DOI: 10.1128/iai.63.4.1263-1269.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  HOST-PARASITE INTERACTION IN PATIENTS WITH INFECTIONS DUE TO ESCHERICHIA COLI. I. THE SEROGROUPING OF E. COLI FROM INTESTINAL AND EXTRAINTESTINAL SOURCES.

Authors:  K L VOSTI; L M GOLDBERG; A S MONTO; L A RANTZ
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

2.  Influence of O and K antigens on the surface properties of Escherichia coli in relation to phagocytosis.

Authors:  O Stendahl; B Normann; L Edebo
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-04

3.  Experimental Escherichia coli urinary infection in the rat.

Authors:  P W Taylor; K G Koutsaimanis
Journal:  Kidney Int       Date:  1975-10       Impact factor: 10.612

4.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  Selection for loss of tetracycline resistance by Escherichia coli.

Authors:  S R Maloy; W D Nunn
Journal:  J Bacteriol       Date:  1981-02       Impact factor: 3.490

6.  Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates.

Authors:  W R McCabe; B Kaijser; S Olling; M Uwaydah; L A Hanson
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

7.  Clofibrate-induced antidiuresis.

Authors:  A M Moses; J Howanitz; M van Gemert; M Miller
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity.

Authors:  H W Smith; M B Huggins
Journal:  J Gen Microbiol       Date:  1980-12

10.  Cell wall composition and virulence in Escherichia coli.

Authors:  D N Medearis; B M Camitta; E C Heath
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

View more
  22 in total

1.  A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Stacy A Genagon; Ulrike MacDonald; John J Cope; Bruce A Davidson; Brian Johnston; James R Johnson
Journal:  Vaccine       Date:  2007-02-05       Impact factor: 3.641

2.  Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts.

Authors:  E Moreno; A Andreu; T Pérez; M Sabaté; J R Johnson; G Prats
Journal:  Epidemiol Infect       Date:  2006-01-26       Impact factor: 2.451

3.  A new O-antigen gene cluster has a key role in the virulence of the Escherichia coli meningitis clone O45:K1:H7.

Authors:  Céline Plainvert; Philippe Bidet; Chantal Peigne; Valérie Barbe; Claudine Médigue; Erick Denamur; Edouard Bingen; Stéphane Bonacorsi
Journal:  J Bacteriol       Date:  2007-09-28       Impact factor: 3.490

4.  Characteristics and prevalence within serogroup O4 of a J96-like clonal group of uropathogenic Escherichia coli O4:H5 containing the class I and class III alleles of papG.

Authors:  J R Johnson; A E Stapleton; T A Russo; F Scheutz; J J Brown; J N Maslow
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli.

Authors:  T A Russo; U B Carlino; J R Johnson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine.

Authors:  T A Russo; U B Carlino; A Mong; S T Jodush
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumonia.

Authors:  Patricia A Manderscheid; Ryan P Bodkin; Bruce A Davidson; Erik Jensen; Thomas A Russo; Paul R Knight
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

9.  A dual component heme biosensor that integrates heme transport and synthesis in bacteria.

Authors:  Christopher L Nobles; Justin R Clark; Sabrina I Green; Anthony W Maresso
Journal:  J Microbiol Methods       Date:  2015-08-04       Impact factor: 2.363

10.  Human neutrophil chemotaxis is modulated by capsule and O antigen from an extraintestinal pathogenic Escherichia coli strain.

Authors:  Thomas A Russo; Bruce A Davidson; Diana M Topolnycky; Ruth Olson; Stacy A Morrill; Paul R Knight; Philip M Murphy
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.